Press Releases

Archived Press Releases

09/03/2008
Plexxikon Initiates Phase 1 Trial for PLX5568
05/21/2008
Plexxikon Announces Preclinical Data Demonstrating Dramatic Improvement in Key Symptoms of Polycystic Kidney Disease
02/19/2008
Plexxikon Announces Publication of Key Data Demonstrating Possible Personalized Medicine for a Variety of Cancers
06/20/2007
Plexxikon Expands Management Team and Board of Directors
10/04/2006
Plexxikon and Roche Enter Partnership to Develop Targeted Cancer Therapeutic Medicine PLX4032
10/03/2006
Plexxikon Files IND Application for Targeted Cancer Therapeutic PLX4032
10/02/2006
Plexxikon and Servier Sign Cardiovascular Collaboration
09/28/2006
Plexxikon Appoints Chief Financial Officer
04/03/2006
Plexxikon Advances First Oncology Development Candidate
04/06/2005
Plexxikon Signs Broad Kinase Screening Collaboration with Invitrogen
12/09/2004
Plexxikon and Phenomix to Develop Drug Candidate for Inflammation
10/28/2004
Plexxikon and Wyeth Collaborate to Develop Novel Treatments for Diabetes and Metabolic Disorders
07/26/2004
Plexxikon Appoints Dr. C. Ronald Kahn of Joslin Diabetes Center to Scientific Advisory Board
11/20/2003
Plexxikon and Phenomix Announce Drug Discovery Collaboration for Oncology and Inflammation Target
11/13/2003
Plexxikon Highlights Research Findings Key to Drug Discovery for Phosphodiesterase Targets
11/11/2003
Plexxikon Achieves Milestone Payment for Lead Compound Selected By Genentech in Drug Discovery Collaboration
05/20/2003
Plexxikon and Genentech Announce Drug Discovery Collaboration for Cancer Target
01/15/2003
Plexxikon's Scaffold-Based Drug Discovery™ Platform To Integrate Synthematix' ARTHUR™ Technology
06/10/2002
Plexxikon Chooses Sun Microsystems and Sun Grid Technology to Power Innovative Drug Discovery Platform
04/16/2002
Plexxikon Raises $27 Million
04/09/2002
Plexxikon Appoints John Kuriyan to Scientific Advisory Board
12/12/2001
Plexxikon Signs Agreement with Scynexis to Accelerate Chemistry Efforts
10/31/2001
Plexxikon Announces Key Additions to Executive Management Team; Launches Corporate Web Site